Nanotechnological developments include diagnostic devices, drug delivery vehicles, and therapeutic agents. These innovations have revolutionized how we think about disease diagnosis and treatment at the cellular level. This issue considers the roles of ethics in shaping legislation, organizational policy, and public discussion about nanomedicine.
Nanoscale materials used to diagnose, monitor, prevent, and treat disease have revolutionized how we think about disease etiology at atomic, molecular, and macromolecular levels. How should ethics respond?
AMA J Ethics. 2019;21(4):E313-316. doi: